MD Anderson Maintains No. 1 Ranking
Conquest - Fall 2010
MD Anderson remains the leading hospital in the nation for cancer care for the fourth year straight, according to the annual “Best Hospitals” survey published by U.S. News & World Report.
This is the seventh time in the last nine years that MD Anderson has ranked number one in the annual listing. Since the survey began in 1990, the institution has been ranked one of the top two cancer hospitals in the United States.
Five MD Anderson subspecialties also were singled out for high rankings:
- Ear, nose and throat (6)
- Urology (10)
- Gynecology (11)
- Gastroenterology (19)
MD Anderson’s ranking in diabetes and endocrinology jumped to 21 this year, up from 41 last year and unranked the year before that.
In a separate survey of pediatric hospitals, published in June by U.S. News & World Report, MD Anderson’s Children’s Cancer Hospital was ranked 12th in the nation.
“We are proud to be ranked again as the top cancer center — an honor that reflects the expertise and accomplishments of our outstanding physicians, researchers, nurses, staff and volunteers, all focused on reducing the burdens of cancer for patients here and everywhere,” says John Mendelsohn, M.D., president of
“The last decade of cancer research has yielded real benefit for patients worldwide, with declining death rates and improving five-year survival rates. To hasten our progress, the need for collaboration among the fine cancer programs recognized by U.S. News & World Report is greater than ever, and we must broaden our cooperation internationally and with government, industry and patients.”
Conquest - Fall 2010
- Branching Out to Conquer Cancer
- Ovarian Cancer Study A Life-Saver
- Programs Nurture Nursing Legacy
- Mohs Surgery Is 'Gold Standard'
- Stem Cell Transplant Patients on the Move
- 'Poster Patient' for Adrenocortical Carcinoma
- Health Disparities Research Continues
- Two Ovarian Cancer Discoveries
- Selenium Not Useful Against Lung Cancer
- Shark Cartilage Extract Shows No Benefit
- New Generation of Drugs for CML
- Also in the News